ATE332307T1 - Wachstumhormonsekretionsförderer - Google Patents

Wachstumhormonsekretionsförderer

Info

Publication number
ATE332307T1
ATE332307T1 AT03714333T AT03714333T ATE332307T1 AT E332307 T1 ATE332307 T1 AT E332307T1 AT 03714333 T AT03714333 T AT 03714333T AT 03714333 T AT03714333 T AT 03714333T AT E332307 T1 ATE332307 T1 AT E332307T1
Authority
AT
Austria
Prior art keywords
growth hormone
hormone secretion
compounds
secretion promoters
novel
Prior art date
Application number
AT03714333T
Other languages
English (en)
Inventor
Britta Evers
Gerd Ruehter
De La Nava Eva Maria Martin
Mark Joseph Tebbe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0208117A external-priority patent/GB0208117D0/en
Priority claimed from GB0208118A external-priority patent/GB0208118D0/en
Priority claimed from GB0208120A external-priority patent/GB0208120D0/en
Priority claimed from GB0208116A external-priority patent/GB0208116D0/en
Priority claimed from GB0208119A external-priority patent/GB0208119D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE332307T1 publication Critical patent/ATE332307T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Golf Clubs (AREA)
  • Conductive Materials (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
AT03714333T 2002-04-09 2003-03-31 Wachstumhormonsekretionsförderer ATE332307T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US37127802P 2002-04-09 2002-04-09
US37127102P 2002-04-09 2002-04-09
US37127702P 2002-04-09 2002-04-09
US37127002P 2002-04-09 2002-04-09
US37127502P 2002-04-09 2002-04-09
GB0208117A GB0208117D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208118A GB0208118D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208120A GB0208120D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208116A GB0208116D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208119A GB0208119D0 (en) 2002-04-09 2002-04-09 Growth Hormone Secretagogues

Publications (1)

Publication Number Publication Date
ATE332307T1 true ATE332307T1 (de) 2006-07-15

Family

ID=29255779

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03716747T ATE338767T1 (de) 2002-04-09 2003-03-31 Dipeptidische wachstumshormonsekretionsförderern
AT03714333T ATE332307T1 (de) 2002-04-09 2003-03-31 Wachstumhormonsekretionsförderer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03716747T ATE338767T1 (de) 2002-04-09 2003-03-31 Dipeptidische wachstumshormonsekretionsförderern

Country Status (7)

Country Link
US (1) US7396846B2 (de)
EP (2) EP1497317B1 (de)
AT (2) ATE338767T1 (de)
AU (2) AU2003220441A1 (de)
DE (2) DE60308166T2 (de)
ES (2) ES2271557T3 (de)
WO (2) WO2003087070A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2346943C2 (ru) * 2003-10-24 2009-02-20 Авентис Фармасьютикалз Инк. Новые соединения и композиции в качестве ингибиторов катепсина
CA2576915A1 (en) 2004-08-18 2006-03-02 Elixir Pharmaceuticals, Inc. Growth-hormone secretagogues
AU2005305593A1 (en) * 2004-11-18 2006-05-26 Pfizer Products Inc. Drugs and prodrugs useful for the treatment of energy balance in ruminants
BRPI0716554A2 (pt) * 2006-09-08 2013-09-24 Bayer Schering Pharma Ag compostos de mÉtodos para agentes rotulados de 18f
JP5268264B2 (ja) * 2007-02-07 2013-08-21 住友精化株式会社 アルカンジスルホニルハライドの製造方法
EP2471363A1 (de) * 2010-12-30 2012-07-04 Bayer CropScience AG Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711495A (en) 1970-01-07 1973-01-16 Merck & Co Inc Isoxazalin-3-yl-substituted-5-nitroimidazoles
DE2359922A1 (de) 1973-12-01 1975-06-05 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)- heteroaryl-verbindungen und verfahren zu ihrer herstellung
US5242903A (en) 1989-08-05 1993-09-07 Bayer Aktiengesellschaft Renin inhibitors
US5206235A (en) 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
US5663146A (en) 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5401851A (en) 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5583130A (en) 1992-09-25 1996-12-10 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
IL107836A (en) 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
SK282166B6 (sk) 1992-12-11 2001-11-06 Merck & Co., Inc. Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom
DE4302957A1 (de) 1993-02-03 1994-08-04 Bayer Ag Imidazolyl-substituierte Phenylessigsäureprolinamide
US5344937A (en) 1993-04-20 1994-09-06 Eli Lilly And Company Alkyl substituted nitroimidazole acetic acids
AU8083694A (en) 1993-10-19 1995-05-08 Merck & Co., Inc. Combination of bisphosphonates and growth hormone secretagogues
US5492916A (en) 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5492920A (en) 1993-12-10 1996-02-20 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US5494919A (en) 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
WO1995014666A1 (en) 1993-11-24 1995-06-01 Merck & Co., Inc. Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
US5721250A (en) 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
ZA9410186B (en) 1994-01-10 1995-08-25 Santiago Abelardo Bojali Jaber Savourless antiamoebic antiprotozoan chemical product and procedure to obtain it
MX9605128A (es) 1994-05-07 1997-08-30 Boehringer Ingelheim Kg Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
US5661161A (en) 1994-09-29 1997-08-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5798337A (en) 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
US5559128A (en) 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
WO1996035713A1 (en) 1995-05-08 1996-11-14 Pfizer, Inc. Dipeptides which promote release of growth hormone
JP3133073B2 (ja) 1995-05-29 2001-02-05 ファイザー・インコーポレーテッド 成長ホルモンの放出を促進するジペプチド類
US5756528A (en) 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1997007117A1 (en) 1995-08-21 1997-02-27 Eli Lilly And Company 2-acylaminopropanamines as growth hormone secretagogues
AU6772996A (en) 1995-08-21 1997-03-12 Eli Lilly And Company 2-acylaminopropanamides as growth hormone secretagogues
BR9610887A (pt) 1995-10-27 1999-07-13 Merck & Co Inc Processo para a preparação de um composto
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997041878A1 (en) 1996-05-07 1997-11-13 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
US5830855A (en) 1996-09-12 1998-11-03 Utah State University Lipodepsipeptides as antifungal and fungicidal agents
JP2001502319A (ja) 1996-10-15 2001-02-20 藤沢薬品工業株式会社 成長ホルモンの放出を促進するベンズオキセピン誘導体
US6046333A (en) 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
WO1998018815A1 (en) 1996-10-25 1998-05-07 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
US6329342B1 (en) 1997-08-19 2001-12-11 Eli Lilly And Company Treatment of congestive heart failure with growth hormone secretagogues
ZA987385B (en) 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.
ZA987383B (en) 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
EP1156808A2 (de) 1998-09-02 2001-11-28 Merck & Co., Inc. Verbesserung der rückkehr zu unabhängigen lebensbedingungen mit einem wachstumshormon-sekretagog
CO5160260A1 (es) * 1999-02-19 2002-05-30 Lilly Co Eli Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido
CZ20031029A3 (cs) * 2000-10-13 2003-09-17 Eli Lilly And Company Substituované dipeptidy jako sekretagogy růstového hormonu
US7750499B2 (en) 2005-11-22 2010-07-06 Lg Electronics Inc. Device for limiting current of electric appliance

Also Published As

Publication number Publication date
DE60306636T2 (de) 2007-07-05
DE60308166D1 (de) 2006-10-19
EP1497316B1 (de) 2006-07-05
US20050240001A1 (en) 2005-10-27
WO2003087070A2 (en) 2003-10-23
WO2003087069A2 (en) 2003-10-23
WO2003087070A3 (en) 2003-12-31
WO2003087069A3 (en) 2004-03-25
EP1497317B1 (de) 2006-09-06
DE60306636D1 (de) 2006-08-17
US7396846B2 (en) 2008-07-08
DE60308166T2 (de) 2007-07-19
AU2003220441A8 (en) 2003-10-27
AU2003218337A8 (en) 2003-10-27
ATE338767T1 (de) 2006-09-15
EP1497316A2 (de) 2005-01-19
ES2271557T3 (es) 2007-04-16
AU2003220441A1 (en) 2003-10-27
ES2266798T3 (es) 2007-03-01
AU2003218337A1 (en) 2003-10-27
EP1497317A2 (de) 2005-01-19

Similar Documents

Publication Publication Date Title
NO20031687D0 (no) Veksthormonsekretagoger
MY138258A (en) Growth hormone secretagogues
MY137040A (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
CY1109998T1 (el) Ενδυναμωτες υποδοχεων γλουταμινικου
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
CY1108156T1 (el) Στερεοεκλεκτικη συνθεση αναλογων βιταμινης d
DK1441724T3 (da) Fremgangsmåde til forögelse af endogene testosteronniveauer
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ATE338767T1 (de) Dipeptidische wachstumshormonsekretionsförderern
MXPA05011289A (es) Compuestos de fosfato que tienen actividad inmunomoduladora.
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
DE50303586D1 (de) Methylthiophencarboxanilide
DE60231987D1 (de) 24-schwefel-substituierte 1-alpha-25-dihydroxy-vitamin-d3-analogen
TW200720225A (en) New one-step synthesis of useful disubstituted amines
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE417055T1 (de) Steroid modifizierte solatriosen
DK1572615T3 (da) Fremgangsmåde til syntese af peptider indeholdende en 4-hydroxyprolin-substruktur
ATE529115T1 (de) Kombinierte verwendung einer prostaglandin- verbindung und eines protonenpumpenhemmers zur behandlung von magen-darm-erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties